척수 자극 기기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Spinal Cord Stimulation Devices Market size is expected to reach USD 6.51 Billion in 2034 from USD 3.03 Billion (2025) growing at a CAGR of 8.86% during 2026-2034.

The Global Spinal Cord Stimulation Devices Market is witnessing significant growth due to the increasing prevalence of chronic pain conditions and neurological disorders. These devices are widely used to manage pain that does not respond to conventional treatments. Growing awareness about minimally invasive pain management options is encouraging patient adoption. Technological advancements in implantable devices are improving patient comfort, safety, and overall treatment effectiveness.

Key market drivers include the aging global population, rising incidence of back pain, and increasing preference for non-opioid pain management solutions. Healthcare providers are increasingly recommending spinal cord stimulation as an alternative to long-term medication use. Improved reimbursement policies and supportive regulatory frameworks are also facilitating market expansion. Manufacturers are focusing on developing rechargeable and wireless devices to enhance convenience and patient satisfaction.

Future prospects for the spinal cord stimulation devices market remain strong as innovation continues in neuromodulation technologies. Advances in device miniaturization, battery life, and programming capabilities are expected to enhance clinical outcomes. Expanding healthcare access in developing regions may further boost demand. As the focus on chronic pain management intensifies globally, spinal cord stimulation devices are likely to play a crucial role in improving patients' quality of life.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Indication

• Failed Back Surgery Syndrome
• Complex Regional Pain Syndrome
• Degenerative Disc Disease
• Others

By Product

• Rechargeable Devices
• Non-Rechargeable Devices

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Saluda Medical Pty Ltd, Nevro Corporation, Abbott Laboratories, Nalu Medical Inc, GIMER MEDICAL, Beijing PINS Medical Co Ltd, Teliatry Inc, Medtronic plc, Boston Scientific Corporation, BIOTRONIK SE amp Co KG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Indication
• 4.2. Failed Back Surgery Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Complex Regional Pain Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Degenerative Disc Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Rechargeable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Non-Rechargeable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Indication
  • 7.2.2 By Product
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Indication
  • 7.3.2 By Product
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Indication
  • 7.4.2 By Product
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Indication
  • 7.5.2 By Product
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Indication
  • 7.6.2 By Product
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SPINAL CORD STIMULATION DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Saluda Medical Pty Ltd
  • 9.2.2 Nevro Corporation
  • 9.2.3 Abbott Laboratories
  • 9.2.4 Nalu Medical Inc
  • 9.2.5 GIMER MEDICAL
  • 9.2.6 Beijing PINS Medical Co. Ltd
  • 9.2.7 Teliatry Inc
  • 9.2.8 Medtronic Plc
  • 9.2.9 Boston Scientific Corporation
  • 9.2.10 BIOTRONIK SE & Co. KG